2025-12-03
抗癌药物开发商
医药研发/制造
化学&生物药
2024-11-20
皮肤病学生物制药商
医药研发/制造
化学&生物药
2024-03-26
生物制剂开发商
医药研发/制造
化学&生物药
ADAR1 Capital Management;
ADAR1 Capital Management;
Lynx1 Capital Management;
Lynx1 Capital Management;
Ikarian Capital
2021-09-29
新型单克隆抗体及细胞治疗技术研发商
医药研发/制造
化学&生物药
Pappas Capital;
Pappas Capital;
Hudson Bay Capital;
Hudson Bay Capital;
Monashee Investment Management;
HBM Healthcare;
Ikarian Capital;
Sphera Global Healthcare Fund;
Soleus Capital;
鱼鹰资管;
Deerfield;
Great Point Partners
2021-04-08
生物制药商
医药研发/制造
化学&生物药
Opaleye Management;
Opaleye Management;
富达国际;
富达国际;
Ikarian Capital;
Surveyor Capital;
Janus Henderson Investors
2021-03-19
口服小分子候选药物研发商
医药研发/制造
化学&生物药
Sio Capital Management,LLC;
Sio Capital Management,LLC;
Driehaus Capital Management;
Driehaus Capital Management;
奥博资本;
Abingworth;
Lincoln Park Capital Fund;
Bain Capital;
Monashee Investment Management;
Ikarian Capital;
Altium Capital
2020-12-11
杜氏肌营养不良症药物研发商
医药研发/制造
化学&生物药
Perceptive Advisors;
Perceptive Advisors;
RA Capital;
RA Capital;
Aspire Capital Fund;
Suvretta Capital Management;
Bain Capital;
EcoR1 Capital;
Boxer Capital;
Ikarian Capital
2020-09-25
细胞治疗疗法开发商
医药研发/制造
化学&生物药
Mesa Verde Venture Partners;
Mesa Verde Venture Partners;
Breakout Ventures;
Breakout Ventures;
Ikarian Capital
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
